SANDIMMUNE by Novartis is clinical pharmacology mechanism of action cyclosporine is a potent immunosuppressive agent, which in animals prolongs survival of allogeneic transplants involving skin, heart, kidney, pancreas, bone marrow, small intestine, and lung. First approved in 1983.
Drug data last refreshed 16h ago · AI intelligence enriched 1w ago
SANDIMMUNE (cyclosporine) is a potent small-molecule immunosuppressant that selectively inhibits T-lymphocyte activation and lymphokine production. It is indicated for organ transplant rejection prophylaxis (kidney, liver, heart) and acts by blocking cell-mediated immunity without suppressing bone marrow or phagocytic function. The drug has been a cornerstone of transplant immunology since FDA approval in 1983.
As LOE approaches, the brand team is likely focused on managed decline, switching strategies to newer agents, and defending core transplant segments against competitive erosion.
CLINICAL PHARMACOLOGY Mechanism of Action Cyclosporine is a potent immunosuppressive agent, which in animals prolongs survival of allogeneic transplants involving skin, heart, kidney, pancreas, bone marrow, small intestine, and lung. Cyclosporine has been demonstrated to suppress some humoral…
Worked on SANDIMMUNE at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers
SANDIMMUNE offers limited new career growth opportunities due to its mature, LOE-approaching status and minimal linked job postings. Roles on this brand typically involve managing stable, high-volume volume markets or defending against erosion rather than building new franchises.